Key facts
- It has raised $2.8M; the latest was Seed Round ($2.5M) in Mar 2025.
- Notable investors include gener8tor, gBETA.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Mitomarin
- ·The full record, as it builds
Funding rounds
No funding rounds for Mitomarin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mitomarin
Operator of a bio and food-tech platform intended to focus on nutritional mitochondrial interventions and novel food development. The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- Budapest, Hungary
- Founded
- 2018
- Employees
- 5
- Website
- mitomarin.hu/
- Ownership
- Privately Held (backing)
Mitomarin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mitomarin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mitomarin in its N-PORT filings yet. We sweep new filings monthly.